EP Biocomposites Limited (BOM:543595)

EP Biocomposites Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	21.54	16.17	12.7	21.92	1.56
Cash & Short-Term Investments	21.54	16.17	12.7	21.92	1.56
Cash Growth	33.20%	27.29%	-42.05%	1304.94%	5.48%
Accounts Receivable	118.42	108.57	89.98	58.61	70.96
Other Receivables	-	-	1.65	-	0.78
Receivables	118.42	108.57	91.62	58.61	71.74
Inventory	13.43	14.11	10.35	10.16	11.83
Other Current Assets	3.97	2.3	10.24	1.93	0.64
Total Current Assets	157.35	141.15	124.92	92.62	85.77
Property, Plant & Equipment	8.46	3.19	3.78	2.02	2.37
Other Intangible Assets	0.08	0.49	0.9	1.32	1.73
Long-Term Deferred Tax Assets	0.28	0.18	0.08	0.01	-
Long-Term Deferred Charges	-	-	-	-	2.22
Other Long-Term Assets	21.15	21.26	21.05	21.28	0.67
Total Assets	187.31	166.27	150.73	117.24	92.77

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	26.86	20.72	29.37	11.85	21.97
Accrued Expenses	5.82	3.38	0.45	2.06	1.13
Short-Term Debt	-	-	6.98	-	18.7
Current Portion of Long-Term Debt	5.26	5.26	-	0.81	0.66
Current Income Taxes Payable	-	3.9	4.25	2.22	3.17
Other Current Liabilities	9.17	2.5	2.99	3.87	4
Total Current Liabilities	47.12	35.76	44.05	20.81	49.63
Long-Term Debt	18.7	24.52	11.04	12.01	21.75
Pension & Post-Retirement Benefits	0.97	0.04	-	0.28	1.35
Long-Term Deferred Tax Liabilities	-	-	-	-	0.05
Total Liabilities	66.78	60.32	55.09	33.1	72.79

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	16.82	16.82	16.82	16.82	11.78
Additional Paid-In Capital	-	53.36	53.36	53.36	-
Retained Earnings	-	35.77	25.47	13.97	8.21
Comprehensive Income & Other	103.72	-	-	-	-
Shareholders' Equity	120.53	105.95	95.64	84.14	19.98
Total Liabilities & Equity	187.31	166.27	150.73	117.24	92.77

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	23.96	29.78	18.02	12.82	41.11
Net Cash (Debt)	-2.42	-13.61	-5.32	9.1	-39.55
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.44	-8.09	-3.16	6.23	-46.35
Filing Date Shares Outstanding	1.69	1.68	1.68	1.68	1.17
Total Common Shares Outstanding	1.69	1.68	1.68	1.68	1.17
Working Capital	110.23	105.38	80.87	71.81	36.14
Book Value Per Share	71.32	63.01	56.88	50.04	17.08
Tangible Book Value	120.45	105.46	94.74	82.83	18.25
Tangible Book Value Per Share	71.28	62.72	56.34	49.26	15.60
Machinery	-	3.84	3.93	2.92	-
Construction In Progress	-	1.35	1.35	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error